-
Aggressive Approach to Very Advanced Cancer Does Not Extend Survival
Study shows no benefit from treatment for cancers at very advanced stages of progression. Researchers urge end-of-life planning for these patients.
by Kyle Bagenstose
-
Telehealth Palliative Care Provides the Same Benefits as In-person Care
Researchers hope effective telehealth will increase access to palliative care for more cancer patients.
by Taneia Surles
-
Chemobrain: It’s Not Your Imagination
Scientists discussed the mechanisms of chemotherapy-related cognitive impairment at a session dedicated to symptom science at the AACR Annual Meeting 2021.
by Marci A. Landsmann
-
Embracing Palliative Care Sooner
Studies show the benefits palliative care can provide to advanced cancer patients, but also highlight inequities in access.
by Jen Tota McGivney
-
Immunotherapy in the Elderly
Immune checkpoint inhibitors can be effective treatments for elderly people with some types of advanced cancer, but more information is needed on their risks and benefits in this group.
by Emma Yasinski
-
Starting a Conversation
Palliative care physician Dawn Gross helps people talk about death by focusing on what they want during life.
by Amy Paturel
-
Putting Chemotherapy Side Effects on Ice
A small study shows that keeping ice chips in the mouth during oxaliplatin chemotherapy may prevent cold sensitivity, a common oral side effect.
by Anna Azvolinsky
-
Palliative Care Pays Off
Patients with advanced cancer who receive palliative care tend to live longer and have better quality of life than those who do not receive this care.
by Cheryl Platzman Weinstock
Cancer Talk
Immunotherapy Improves Survival in Bladder Cancer
New research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
2024: The Year in Cancer NewsThe Cancer Today editors share the most impactful reporting on cancer research from 2024.
by Cancer Today staff